Hydroxychloroquine, Chloroquine, and Arrhythmic Risk in Systemic Autoimmune Diseases: Focus More on the Patient and You Will Keep the Rhythm!

J Cardiovasc Pharmacol. 2024 Aug 1;84(2):149-151. doi: 10.1097/FJC.0000000000001594.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use
  • Arrhythmias, Cardiac* / chemically induced
  • Arrhythmias, Cardiac* / physiopathology
  • Autoimmune Diseases* / drug therapy
  • Autoimmune Diseases* / epidemiology
  • Chloroquine* / adverse effects
  • Chloroquine* / therapeutic use
  • Heart Rate / drug effects
  • Humans
  • Hydroxychloroquine* / adverse effects
  • Hydroxychloroquine* / therapeutic use
  • Risk Assessment
  • Risk Factors

Substances

  • Hydroxychloroquine
  • Chloroquine
  • Antirheumatic Agents